Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07653087 · ClinicalTrials.gov registry record · NA
Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma
A NA study, sponsored by University of Virginia.
- Not yet
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT07653087 is a NA study that has not yet begun recruiting, run by University of Virginia. The registered enrollment target is 66 participants.
The verdict
NCT07653087, a NA study, has not yet begun recruiting, sponsored by University of Virginia.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
This research study is testing a decision aid to help patients think through whether to have sentinel lymph node biopsy for melanoma. Sentinel lymph node biopsy (SLNB) can be a difficult decision for some patients because the potential benefits and risks may not be clear. This study is being done to learn whether providing structured, easy-to-understand information helps patients feel more informed and less uncertain about their decision. Patients in this study will be given a paper decision aid (DA). Patients will be given other short questionnaires to complete before and after the decision aid.
Interventions
- OTHER Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2026-06 |
| Est. Completion | 2028-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07653087
The ClinicalTrials.gov registry entry for NCT07653087 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Decision Aid is the first listed.
NCT07653087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07653087 about?
NCT07653087 is a clinical study titled "Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma". This research study is testing a decision aid to help patients think through whether to have sentinel lymph node biopsy for melanoma. Sentinel lymph node biopsy (SLNB) can be a difficult decision for some patients because the potential benefits and risks may not be clear. This study is being done t...
What is the current status of trial NCT07653087?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2026-06. Estimated completion is 2028-01.
What interventions are being tested in trial NCT07653087?
The interventions under investigation include: Decision Aid (OTHER).
Who is sponsoring clinical trial NCT07653087?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.